ALKS vs JD · P/E 14, rev $1.56B vs P/E 7.6, rev $187.20B
Alkermes Plc (ALKS) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the ALKS and JD stock pages for the full models.
Not investment advice.